MEGURI Research
Japan’s Hidden Psychedelic History
Sacred cannabis in Shinto, native psilocybin species, shamanic traditions severed by occupation-era law — Japan's entheogenic heritage runs deeper than most realize.
14,000+
Years of Cannabis Use in Japan
Archaeological evidence, Jōmon period
30+
Native Psilocybin Species
Yokoyama 1973 / Koike et al.
1948
Cannabis Control Act Imposed
GHQ/SCAP directive
0
Legal Psychedelic Therapies in Japan
All scheduled as of 2025
Ancient Origins — Mushrooms & Mountains
Japan's relationship with psychoactive fungi stretches back to its earliest human cultures. While definitive proof of ritual psychedelic use in prehistoric Japan remains elusive, the archaeological and mycological evidence is suggestive.
Jōmon Mushroom Figures (縄文キノコ形土製品)
Clay figurines from the Jōmon period (14,000–300 BCE) found in Tohoku and Chubu regions depict what appear to be mushroom-shaped forms. While their exact purpose is debated among archaeologists, several scholars (including Furst 1976 and Samorini 1992) have drawn parallels to mushroom cults found in Mesoamerica. The famous 'mushroom stone' from Aomori Prefecture dates to approximately 2000 BCE. Whether these represent psychoactive mushrooms or food mushrooms (Japan has a deep mycophilic culture) remains unresolved.
Beni-tengu-take (ベニテングタケ / Amanita muscaria)
The iconic red-and-white fly agaric mushroom grows natively in Japan's birch and conifer forests, particularly in Hokkaido and highland areas of Honshu. Japanese folklore connects it to tengu — the long-nosed mountain spirits of Shinto-Buddhist syncretism. The name itself (beni = red, tengu-take = tengu mushroom) embeds this connection. Amanita muscaria contains muscimol and ibotenic acid (not psilocybin); its psychoactive effects include delirium, altered perception, and lucid dreaming. Wasson (1968) controversially proposed Amanita muscaria as the identity of Soma in the Rigveda. In Siberian shamanic traditions, which share deep links with Ainu and early Japanese cultures, Amanita muscaria was used ceremonially.
Native Psilocybin Species
Japan hosts over 30 species of psilocybin-containing mushrooms. The most well-known are Psilocybe subcaerulipes (ヒカゲシビレタケ, found on decaying wood in warm, humid forests), Psilocybe argentipes (オオシビレタケ), and Panaeolus papilionaceus (ワライタケ). Yokoyama's 1973 survey was the first systematic identification. These species were not explicitly regulated until 2002, when Japan added psilocybin and psilocin to its controlled substances list following media coverage of recreational use. Before 2002, magic mushrooms were sold openly in shops in Tokyo, Osaka, and tourist areas — a fact that surprises many observers of Japan's current strict drug enforcement.
The kami dwell in hemp. To sever hemp from Shinto is to sever Shinto from its roots.
— Junichi Takayasu, hemp scholar
Cannabis & Shinto — The Sacred Plant
Perhaps no single plant illustrates the disconnect between Japan's spiritual heritage and modern drug policy more starkly than cannabis. For centuries a sacred offering to the kami, it was criminalized almost overnight by a foreign occupying power.
Cannabis (taima, 大麻) held a central place in Shinto ritual life for centuries. The plant was considered one of the most sacred offerings to the kami. At Ise Jingu, Japan's most important shrine, the talisman distributed to households across Japan is called 'taima' (お神札 / 神宮大麻) — literally 'great cannabis.' Shimenawa (sacred ropes) marking the boundary between the sacred and profane were traditionally made from hemp fiber. Hemp was used in purification rituals (harae), and priests would burn hemp seeds as an offering. The gohei (paper streamers on a wand) originally used hemp fiber. Cannabis was not merely a useful crop — it was a conduit to the divine.
Before 1948, cannabis cultivation was widespread across Japan, with an estimated 20,000+ hectares under cultivation. Hemp fiber was used for clothing (particularly the kimono inner layers and peasant garments), paper, rope, fishing nets, and bow strings. Place names across Japan reflect this heritage: Asago (麻生), Omi (麻織), Asahikawa (旭川, originally written with the hemp character). Tokushima Prefecture was the center of hemp cultivation, and traditional awa-taima (阿波大麻) cultivation continues on a very small scale today for Shinto ceremonial use, requiring special government permission.
During the US occupation (1945–1952), GHQ/SCAP (Supreme Commander for the Allied Powers) imposed the Cannabis Control Act (Taima Torishimari Hō) in 1948 as part of broader narcotics legislation. This was driven by American drug policy of the era, not by any Japanese tradition of cannabis abuse. Japan had no history of recreational cannabis smoking — the prohibition was an imported policy. The law banned cultivation, possession, and transfer. The irony is stark: a substance central to Japan's oldest spiritual tradition (Shinto) was criminalized at the direction of a foreign occupying power. In 2023, Japan amended the law to explicitly criminalize recreational cannabis use (previously only cultivation and possession were illegal, not consumption itself), while also beginning discussions about medical cannabis access.
Consciousness-Altering Plants in Japanese Tradition
Beyond cannabis and psilocybin mushrooms, Japan has a rich tradition of using plants that modify consciousness — for healing, purification, and spiritual practice.
Mugwort (ヨモギ / Artemisia indica)
Mugwort occupies a unique space in Japanese spiritual herbalism. Used in moxibustion (moxa/お灸) for over 1,000 years, it is also burned in purification rituals. On May 5 (Children's Day), mugwort is placed in baths (菖蒲湯/しょうぶ湯) for its protective properties. In folk medicine, mugwort tea and smoke were used to induce vivid dreams and facilitate communication with spirits. While not a classical psychedelic, mugwort's thujone content can produce mild perceptual changes. European traditions similarly associate Artemisia species with altered consciousness (absinthe from A. absinthium). The plant bridges the boundary between medicinal herb, purification agent, and consciousness modifier.
Datura (チョウセンアサガオ / ダツラ)
Datura stramonium and D. metel grow in Japan and were known in Kampo medicine as 'mandarage' (曼陀羅華, named after the Buddhist mandala flower). The alkaloids (scopolamine, atropine, hyoscyamine) produce powerful delirium and hallucinations. In Edo-period literature, datura appears as a poison and a tool for sorcery. Hanaoka Seishū (華岡青洲, 1760–1835), the surgeon who performed the world's first documented general anesthesia (1804), used a formula called 'mafutsusan' (通仙散) that included Datura as a key ingredient. This was a legitimate medical use of a plant whose psychoactive properties were well understood. Datura is extremely dangerous and has a narrow margin between active and lethal doses.
Kampo & Consciousness-Altering Herbs
Kampo (漢方) medicine, Japan's adaptation of Chinese herbal medicine, includes several herbs with psychoactive properties used within carefully calibrated formulas. Aconitum (bushi/附子) produces altered states in toxic doses. Ephedra (maou/麻黄) is a stimulant. Cannabis seeds (mashinin/麻子仁) appeared in classical Kampo formulas. The distinction between 'medicine' and 'drug' was fluid in pre-modern Japan — the same character, yaku (薬), means both. Kampo practitioners understood that consciousness modification was sometimes necessary for healing. This nuanced approach contrasts sharply with modern Japan's binary framework of 'legal medicine' versus 'illegal drug.'
To prohibit is not to erase. The plants remember, even when the people forget.
— Anonymous Shinto priest
Modern Japan & the Global Renaissance
While the world moves toward psychedelic decriminalization and medical access, Japan remains largely outside this conversation. Yet beneath the surface, cracks are forming.
Japan maintains some of the strictest drug laws in the developed world. The Stimulants Control Act (1951), Cannabis Control Act (1948), and Narcotics and Psychotropics Control Act (1953) create a comprehensive framework. Psilocybin and psilocin were added to the controlled substances list in 2002. Penalties are severe: cannabis possession alone can carry up to 5 years imprisonment (7 years with intent to distribute). Celebrity drug arrests receive massive media coverage and result in career destruction, reinforcing social stigma. Japan's conviction rate exceeds 99%, and the 'confession first' culture of policing makes drug cases particularly harsh. The 2023 amendment further tightened cannabis regulations by criminalizing use itself (not just possession).
Despite Japan's restrictive legal environment, Japanese scientists have made significant contributions to psychedelic research. Jokichi Takamine isolated adrenaline (1901) and was a pioneer in psychopharmacology. Nagayoshi Nagai first synthesized methamphetamine (1893) and ephedrine. More recently, researchers at Keio University, University of Tokyo, and RIKEN have published work on serotonin receptor neuroscience relevant to psychedelic mechanisms. Torsten Passie (a German researcher who has collaborated with Japanese institutions) notes that Japan's neuroscience infrastructure is world-class, but regulatory barriers prevent clinical psychedelic research. A small but growing community of Japanese psychiatrists and neuroscientists advocate for research access, often citing the global evidence base.
Aokigahara (青木ヶ原), the dense forest at the base of Mt. Fuji, is known internationally for its association with suicide. But the forest has deeper cultural dimensions. In Shugendo and folk tradition, Aokigahara is considered a 'spirit forest' where the boundary between worlds is thin. The forest's properties — magnetic anomalies from volcanic rock, extreme silence (sound-absorbing moss and lava formations), sensory uniformity that induces disorientation — can produce altered states without any substance. Forest bathing (shinrin-yoku) research by Qing Li (2018) documented measurable physiological changes from immersion in Japanese forests. Aokigahara represents an extreme case: a landscape that alters consciousness through environmental properties alone. This resonates with the broader SBNR insight that altered states are natural human capacities, not aberrations.
The SBNR Lens — Reconnecting Japan to Its Roots
Japan's psychedelic history is not a curiosity — it is a case study in how colonial drug policy can sever a culture from its own spiritual tools. The SBNR perspective asks: what is lost, and what might be recovered?
The Great Disconnect
Japan presents a unique paradox in the global psychedelic landscape. Here is a nation with deep plant-medicine heritage (sacred cannabis in Shinto, consciousness-altering herbs in Kampo, native psilocybin species, shamanic traditions in Ainu and Shugendo cultures) that simultaneously maintains some of the world's strictest prohibitions on these very substances. The 1948 Cannabis Control Act and 2002 mushroom ban severed Japan from its own entheogenic traditions. This disconnect is not merely legal — it is cultural and spiritual. Many Japanese people are unaware of their country's pre-prohibition relationship with these plants.
Rediscovery as SBNR Practice
For the SBNR perspective, Japan's situation illuminates a broader question: what happens when a culture is severed from its own entheogenic roots? Japan's 'religious but not spiritual' paradox (high ritual participation, low belief) may partly reflect this disconnection. The elements for reconnection exist: Japan's mycological expertise is world-class, its neuroscience infrastructure is cutting-edge, and its spiritual traditions (Zen, Shugendo, Shinto purification) provide rich frameworks for integrating psychedelic experiences. What is missing is not knowledge or tradition but political will and cultural permission. As the global psychedelic renaissance accelerates, Japan faces a choice: continue prohibition or rediscover what was always its own.
Sources & References
- Takayasu, J. Taima to Nihonjin (\u5927\u9EBB\u3068\u65E5\u672C\u4EBA). Shueisha, 2014.
- Furst, P. T. Hallucinogens and Culture. Chandler & Sharp, 1976.
- Samorini, G. “The oldest representations of hallucinogenic mushrooms in the world.” Integration, 2/3, 1992.
- Wasson, R. G. Soma: Divine Mushroom of Immortality. Harcourt, 1968.
- Yokoyama, K. “Survey of psilocybin-containing fungi in Japan.” 1973.
- Li, Q. Shinrin-Yoku: The Art and Science of Forest Bathing. Penguin, 2018.
- Ministry of Health, Labour and Welfare. Cannabis Control Act amendments. 2023.
- Matsumoto, T. “Drug abuse trends in Japan.” Psychiatry and Clinical Neurosciences, 2019.
- Hanaoka, S. Records of general anesthesia using Mafutsusan (通仙散). 1804.
- Passie, T. “International perspectives on psychedelic research.” Pharmacopsychiatry, 2022.